ScripAfter its bid to acquire Canada's Bioasis Technologies, Inc. hit the rocks, UK group Biodexa Pharmaceuticals , formerly Midatech Pharma PLC , is looking to combine with Varian Biopharmaceuticals
ScripMidatech Pharma PLC ’s hopes of survival have been badly damaged by its own shareholders who have voted against the UK firm's proposed merger with Bioasis Technologies, Inc. . With cash reserves rapi
ScripWith cash rapidly running out, the UK's Midatech Pharma PLC hopes to have secured its future by merging with Bioasis Technologies, Inc. to create "a multi-asset rare and orphan disease company" th
Pink SheetAfter a year of transition, Midatech Pharma US Inc. finally has completed the evolution from a development-stage company to a commercial organization specializing in oncology support therapeutics.